Principal Investigator
Maria Alcaide
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20191305
Clinical Trial Summary
A Randomized, Double-blind, Placebo-controlled, Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of ABBV-181 in HIV-1 Infected Adults
Phase
Phase I
Funding Agency/Sponsor
Industry
Disease
Infectious Diseases
Contact Information
Study Contact
Marilyn Fernandez
Phone Number
+1 (305) 2433834 x63834
Email
mxf383@miami.edu